Elaine Willmore

A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia

Elaine Willmore, Sarah de Caux, Nicola J. Sunter et al. · Blood · 2004 · 265 citations · Full text

Etoposide Targets Topoisomerase IIα and IIβ in Leukemic Cells: Isoform-Specific Cleavable Complexes Visualized and QuantifiedIn Situ by a Novel Immunofluorescence Technique

Elaine Willmore, Adrian Frank, Kay Padget et al. · Molecular Pharmacology · 1998 · 146 citations

The Novel Poly(ADP-Ribose) Polymerase Inhibitor, AG14361, Sensitizes Cells to Topoisomerase I Poisons by Increasing the Persistence of DNA Strand Breaks

Lisa M. Smith, Elaine Willmore, Caroline A. Austin et al. · Clinical Cancer Research · 2005 · 125 citations

Apoptosis, Cell Death, Molecular Biology +17

Expression, Domain Structure, and Enzymatic Properties of an Active Recombinant Human DNA Topoisomerase IIβ

Caroline A. Austin, Katherine L. Marsh, Robin Ann Wasserman et al. · Journal of Biological Chemistry · 1995 · 107 citations · Full text

The dietary flavonoids myricetin and fisetin act as dual inhibitors of DNA topoisomerases I and II in cells

Miguel López‐Lázaro, Elaine Willmore, Caroline A. Austin · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 2009 · 101 citations

Dna Topoisomerases, Biochemistry, Medicine +7